Help - Search - Members - Calendar
Full Version: Anaphylactic Shock
Online Medical Forum > Library Database Of Journals Publications Researches Category > Library Database Of Journals Publications Researches > Medicine Category > Internal Medicine Forum > Medicine Topics > Anaphylactic Shock
Pages: 1, 2, 3
  1. Anaphylactic-Shock: Safety of barley starch syrup in patients with allergy to cereals. (0 replies)
  2. Anaphylactic-Shock: Pulseless electrical activity during caesarean delivery under spinal anaesthesia: a case report of severe anaphylactic reaction to syntocinon. (0 replies)
  3. Anaphylactic-Shock: Soybean β-conglycinin as the main allergen in a patient with food-dependent exercise-induced anaphylaxis by tofu: food processing alters pepsin resistance (0 replies)
  4. Anaphylactic-Shock: Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis i (0 replies)
  5. Anaphylactic-Shock: Anaphylaxis fatalities and admissions in australia. (0 replies)
  6. Anaphylactic-Shock: [active drug monitoring of adverse drug reactions in pediatric emergency department.] (0 replies)
  7. Anaphylactic-Shock: Suspected anaphylactic reactions associated with anaesthesia (0 replies)
  8. Anaphylactic-Shock: Chlorhexidine: anaphylaxis following urethral administration: 3 case reports. (0 replies)
  9. Anaphylactic-Shock: Evaluation of antiasthmatic activity of <i>curculigo orchioides </i>gaertn. rhizomes (0 replies)
  10. Anaphylactic-Shock: Chlorhexidine: anaphylaxis following urethral administration: 3 case reports (0 replies)
  11. Anaphylactic-Shock: Management of anaphylaxis in children. (0 replies)
  12. Anaphylactic-Shock: Management of anaphylaxis in children. (0 replies)
  13. Anaphylactic-Shock: Measles virus vaccine live/rubella virus vaccine live: anaphylaxis in infants: 3 case reports. (0 replies)
  14. Anaphylactic-Shock: Sodium chloride: anaphylaxis: case report. (0 replies)
  15. Anaphylactic-Shock: Positive and negative regulatory mechanisms in high-affinity ige receptor-mediated mast cell activation (0 replies)
  16. Anaphylactic-Shock: Sophora flavescens aiton inhibits the production of pro-inflammatory cytokines through inhibition of the nf kappab/ikappab signal pathway in human mast cell line (hmc-1). (0 replies)
  17. Anaphylactic-Shock: Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with ige antibodies specific for galactose-alpha-1,3-galactose. (0 replies)
  18. Anaphylactic-Shock: Characteristics of food-allergic patients placing them at risk for a fatal anaphylactic episode (0 replies)
  19. Anaphylactic-Shock: General anesthetic allergy testing (0 replies)
  20. Anaphylactic-Shock: The problem of anaphylaxis and mastocytosis (0 replies)
  21. Anaphylactic-Shock: Anaphylaxis (0 replies)
  22. Anaphylactic-Shock: Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ecrit study (0 replies)
  23. Anaphylactic-Shock: Targeting the mhc class ii pathway of antigen presentation enhances immunogenicity and safety of allergen immunotherapy (0 replies)
  24. Anaphylactic-Shock: Alternative algorithm for l-asparaginase allergy in children with acute lymphoblastic leukemia. (0 replies)
  25. Anaphylactic-Shock: Bilateral parotidomegaly following anaphylaxis to infliximab (0 replies)
  26. Anaphylactic-Shock: Allergy alerts reach a record level, uk (0 replies)
  27. Anaphylactic-Shock: Benzylpenicillin/epinephrine: anaphylaxis in mother and hypotonia, bradycardia and hypoxic-ischaemic encephalopathy in neonate: 2 case reports. (0 replies)
  28. Anaphylactic-Shock: Nonsteroidal anti-inflammatories: asthma, urticaria and anaphylaxis: 4 case reports. (0 replies)
  29. Anaphylactic-Shock: Orthophthalaldehyde: anaphylaxis: 2 case reports. (0 replies)
  30. Anaphylactic-Shock: Benzylpenicillin/epinephrine: anaphylaxis in mother and hypotonia, bradycardia and hypoxic-ischaemic encephalopathy in neonate: 2 case reports (0 replies)
  31. Anaphylactic-Shock: Nonsteroidal anti-inflammatories: asthma, urticaria and anaphylaxis: 4 case reports (0 replies)
  32. Anaphylactic-Shock: Orthophthalaldehyde: anaphylaxis: 2 case reports (0 replies)
  33. Anaphylactic-Shock: Incidence and characteristics of biphasic reactions after allergen immunotherapy. (0 replies)
  34. Anaphylactic-Shock: Anaphylaxis to husband's seminal plasma and treatment by local desensitization (0 replies)
  35. Anaphylactic-Shock: Anaphylaxis to the chlorhexidine component of instillagel(r): a case series (0 replies)
  36. Anaphylactic-Shock: Sialic acid residues are essential for the anaphylactic activity of murine igg1 antibodies. (0 replies)
  37. Anaphylactic-Shock: An unusual cause of allergy case report of normal saline solution allergy. (0 replies)
  38. Anaphylactic-Shock: Aprotinin/rocuronium bromide: anaphylaxis in a patient with prior exposure to aprotinin and rocuronium: case report. (0 replies)
  39. Anaphylactic-Shock: Atracurium besilate/fentanyl/propofol: anaphylaxis, treated with vasopressin: case report. (0 replies)
  40. Anaphylactic-Shock: Methylprednisolone hydrogen succinate: anaphylaxis: case report. (0 replies)
  41. Anaphylactic-Shock: Anti-allergic effects of teucrium japonicum on mast cell-mediated allergy model. (0 replies)
  42. Anaphylactic-Shock: Scientists developing food allergy treatment (0 replies)
  43. Anaphylactic-Shock: Aprotinin/rocuronium bromide: anaphylaxis in a patient with prior exposure to aprotinin and rocuronium: case report (0 replies)
  44. Anaphylactic-Shock: Atracurium besilate/fentanyl/propofol: anaphylaxis, treated with vasopressin: case report (0 replies)
  45. Anaphylactic-Shock: Methylprednisolone hydrogen succinate: anaphylaxis: case report (0 replies)
  46. Anaphylactic-Shock: The use of pharmaceuticals for dialysis patients. how well do we know our patients' allergies? (0 replies)
  47. Anaphylactic-Shock: Acute coronary syndrome in cisatracurium-induced anaphylactic shock: kounis syndrome. (0 replies)
  48. Anaphylactic-Shock: Anti-allergic activity of an ethanol extract from salviae miltiorrhiza. (0 replies)
  49. Anaphylactic-Shock: Design and modifications of allergens for improving specific immunotherapy. (0 replies)
  50. Anaphylactic-Shock: Recent advances in radiation therapy. (0 replies)
  51. Anaphylactic-Shock: Scientists developing safer food allergy treatment (0 replies)
  52. Anaphylactic-Shock: Scientists developing food allergy treatment (0 replies)
  53. Anaphylactic-Shock: Emergency pretreatment for contrast allergy before direct percutaneous coronary intervention for st-elevation myocardial infarction. (0 replies)
  54. Anaphylactic-Shock: A case of isocyanate-induced asthma possibly complicated by food allergy after peanut consumption: a case report (0 replies)
  55. Anaphylactic-Shock: Impact of native, heat-processed and encapsulated hazelnuts on the allergic response in hazelnut-allergic patients (0 replies)
  56. Anaphylactic-Shock: National charity calls for improved allergy services following tragic death, uk (0 replies)
  57. Anaphylactic-Shock: Unusual presentation of spontaneous pneumomediastinum: a case report (0 replies)
  58. Anaphylactic-Shock: Incidence and prevalence of multiple allergic disorders recorded in a national primary care database (0 replies)
  59. Anaphylactic-Shock: Oxybenzone: anaphylaxis: case report. (0 replies)
  60. Anaphylactic-Shock: Rgs13 controls g protein-coupled receptor-evoked responses of human mast cells. (0 replies)
  61. Anaphylactic-Shock: Oxybenzone: anaphylaxis: case report (0 replies)
  62. Anaphylactic-Shock: New types of immunotherapy in children (0 replies)
  63. Anaphylactic-Shock: Biomarkers in the diagnosis of anaphylaxis: making nature disclose her mysteries (0 replies)
  64. Anaphylactic-Shock: New study data: januvia (sitagliptin) significantly reduced blood sugar levels and was not associated with hypoglycemia in elderly patients with type 2 diabetes (0 replies)
  65. Anaphylactic-Shock: Adverse reactions to ant stings (0 replies)
  66. Anaphylactic-Shock: Anaphylaxis and superior vena cava thrombus in a pediatric patient with acute lymphoblastic leukemia. (0 replies)
  67. Anaphylactic-Shock: Validation of gel-free, label-free quantitative proteomics approaches: applications for seed allergen profiling. (0 replies)
  68. Anaphylactic-Shock: Impairing oral tolerance promotes allergy and anaphylaxis: a new murine food allergy model. (0 replies)
  69. Anaphylactic-Shock: [complete heart block and myocardial ischaemia during a severe anaphylactic reaction.] (0 replies)
  70. Anaphylactic-Shock: Sulphan blue: anaphylaxis with heart arrest: case report (0 replies)
  71. Anaphylactic-Shock: [latex induced anaphylactic shock during caesarean section: two cases from guadeloupe.] (0 replies)
  72. Anaphylactic-Shock: [polidocanol induced cardiotoxicity: a case report and review of the literature.] (0 replies)
  73. Anaphylactic-Shock: Blood transfusion-induced anaphylaxis and coronary artery spasm during general anesthesia (0 replies)
  74. Anaphylactic-Shock: Sulphan blue: anaphylaxis with heart arrest: case report. (0 replies)
  75. Anaphylactic-Shock: World apheresis registry data from 2003 to 2007, the pediatric and adolescent side of the registry. (0 replies)
  76. Anaphylactic-Shock: Anaphylaxis in the emergency department: a paediatric perspective (0 replies)
  77. Anaphylactic-Shock: Hypersensitivity to antineoplastic agents. (0 replies)
  78. Anaphylactic-Shock: Hypersensitivity reactions to anticoagulant drugs. (0 replies)
  79. Anaphylactic-Shock: Cross-reactive reactions to nonsteroidal anti-inflammatory drugs. (0 replies)
  80. Anaphylactic-Shock: Hypersensitivity reactions to neuromuscular blocking agents. (0 replies)
  81. Anaphylactic-Shock: Anaphylaxis in the emergency department: a paediatric perspective (0 replies)
  82. Anaphylactic-Shock: Effects of early endotoxemia and dextran-induced anaphylaxis on the size-selectivity of the glomerular filtration barrier in rats. (0 replies)
  83. Anaphylactic-Shock: Acaai: schools earn poor grade on food allergy action plans (0 replies)
  84. Anaphylactic-Shock: Anaphylaxis hospitalizations on rise among people younger than 20 (0 replies)
  85. Anaphylactic-Shock: A small amount of tetrachloroethylene ingestion from drinking water accelerates antigen-stimulated allergic responses. (0 replies)
  86. Anaphylactic-Shock: [protein structure and folding] crystal structure of human plasma platelet-activating factor acetylhydrolase: structural implication to lipoprotein binding and catalysis (0 replies)
  87. Anaphylactic-Shock: Targeting il-4/il-13 signaling to alleviate oral allergen-induced diarrhea. (0 replies)
  88. Anaphylactic-Shock: Soybean (glycine max) allergy in europe: gly m 5 (beta-conglycinin) and gly m 6 (glycinin) are potential diagnostic markers for severe allergic reactions to soy. (0 replies)
  89. Anaphylactic-Shock: Phase i study of paclitaxel with standard dose ifosfamide in children with refractory solid tumors: a pediatric oncology group study (pog 9376) (0 replies)
  90. Anaphylactic-Shock: Genetic inversion in mast cell-deficient wsh mice interrupts corin and manifests as hematopoietic and cardiac aberrancy. (0 replies)
  91. Anaphylactic-Shock: Idiopathic anaphylaxis successfully treated with omalizumab (0 replies)
  92. Anaphylactic-Shock: Anaphylaxis caused by tangerine seeds but not tangerine fruit (0 replies)
  93. Anaphylactic-Shock: The etiology and incidence of anaphylaxis in rochester, minnesota: a report from the rochester epidemiology project. (0 replies)
  94. Anaphylactic-Shock: Cefoperazone/sulbactam: anaphylaxis: case report (0 replies)
  95. Anaphylactic-Shock: Hypothesis: hemolytic transfusion reactions represent an alternative type of anaphylaxis. (0 replies)
  96. Anaphylactic-Shock: Anaphylaxis due to methylprednisolone. (0 replies)
  97. Anaphylactic-Shock: Allergen-sensitization increases mast-cell expression of the exocytotic proteins snap-23 and syntaxin 4, which are involved in histamine secretion. (0 replies)
  98. Anaphylactic-Shock: Study of hypersensitivity reactions and anaphylaxis during anesthesia in spain. (0 replies)
  99. Anaphylactic-Shock: Cefoperazone/sulbactam: anaphylaxis: case report. (0 replies)
  100. Anaphylactic-Shock: Wasp sting: an unusual fatal outcome. (0 replies)
  101. Anaphylactic-Shock: Anti-inflammatory activity of pectolinarigenin and pectolinarin isolated from cirsium chanroenicum. (0 replies)
  102. Anaphylactic-Shock: Bovine serum albumin contained in culture medium used in artificial insemination is an important anaphylaxis risk factor (0 replies)
  103. Anaphylactic-Shock: Development and validation of a self-administered food allergy quality of life questionnaire for children (0 replies)
  104. Anaphylactic-Shock: Resuscitation skills for radiologists: a short paper (0 replies)
  105. Anaphylactic-Shock: A practical approach to paediatric emergencies in the radiology department (0 replies)
  106. Anaphylactic-Shock: Increased production of cysteinyl leukotrienes and prostaglandin d2 during human anaphylaxis (0 replies)
  107. Anaphylactic-Shock: [mechanisms of signal transduction] attenuation of ige affinity for fc{epsilon}ri radically reduces the allergic response in vitro and in vivo (0 replies)
  108. Anaphylactic-Shock: Prevesical hydatid cyst: an exceptional occurrence (0 replies)
  109. Anaphylactic-Shock: Epinephrine has been confirmed as the drug of choice for anaphylaxis (0 replies)
  110. Anaphylactic-Shock: [case reports] anaphylaxis following single component measles and rubella immunisation (0 replies)
  111. Anaphylactic-Shock: Immediate anaphylactic death following antibiotics injection: splenic eosinophilia easily revealed by pagoda red stain. (0 replies)
  112. Anaphylactic-Shock: Epinephrine has been confirmed as the drug of choice for anaphylaxis. (0 replies)
  113. Anaphylactic-Shock: Home treatment with elapraseŽ and naglazymeŽ is safe in patients with mucopolysaccharidoses types ii and vi, respectively (0 replies)
  114. Anaphylactic-Shock: Primary care live annual conference and exhibition (excel, london) (0 replies)
  115. Anaphylactic-Shock: Anaphylaxis: educational programs are needed. (0 replies)
  116. Anaphylactic-Shock: Management and successful desensitization in methotrexate-induced anaphylaxis (0 replies)
  117. Anaphylactic-Shock: Amoxicillin/clavulanic acid: anaphylaxis, complicated by stent thrombosis: case report (0 replies)
  118. Anaphylactic-Shock: Bacitracin: anaphylaxis: case report (0 replies)
  119. Anaphylactic-Shock: Cinnamon: anaphylaxis: case report (0 replies)
  120. Anaphylactic-Shock: Inulin: iga nephropathy (first report) and anaphylaxis in a child: case report (0 replies)
  121. Anaphylactic-Shock: What are the most common food allergies? (0 replies)
  122. Anaphylactic-Shock: Amoxicillin/clavulanic acid: anaphylaxis, complicated by stent thrombosis: case report. (0 replies)
  123. Anaphylactic-Shock: Bacitracin: anaphylaxis: case report. (0 replies)
  124. Anaphylactic-Shock: Cinnamon: anaphylaxis: case report. (0 replies)
  125. Anaphylactic-Shock: Inulin: iga nephropathy (first report) and anaphylaxis in a child: case report. (0 replies)
  126. Anaphylactic-Shock: Anaphylaxis after hpv vaccination 'rare' (0 replies)
  127. Anaphylactic-Shock: Anaphylaxis (0 replies)
  128. Anaphylactic-Shock: Maize food allergy: a double-blind placebo-controlled study (0 replies)
  129. Anaphylactic-Shock: Hpv jab has higher anaphylaxis risk (0 replies)
  130. Anaphylactic-Shock: Anaphylactic shock to penicillin. (0 replies)
  131. Anaphylactic-Shock: Anaphylactic shock with coronary stenting thrombosis induced by amoxicillin-clavulanic acid. (0 replies)
  132. Anaphylactic-Shock: Herbex-kid inhibits immediate hypersensitivity reactions in mice and rats (0 replies)
  133. Anaphylactic-Shock: Epidemiology of anaphylaxis. (0 replies)
  134. Anaphylactic-Shock: Rate of anaphylaxis after hpv vaccine higher than other vaccines, australians report (0 replies)
  135. Anaphylactic-Shock: Hpv vaccine linked to high rate of anaphylaxis (0 replies)
  136. Anaphylactic-Shock: Hpv vaccine deemed safe despite higher anaphylaxis rates (0 replies)
  137. Anaphylactic-Shock: Should children with a history of anaphylaxis to foods undergo challenge testing? (0 replies)
  138. Anaphylactic-Shock: Anaphylaxis increases after hpv shot (0 replies)
  139. Anaphylactic-Shock: Cmaj study reveals higher anaphylaxis rates after hpv vaccination (0 replies)
  140. Anaphylactic-Shock: Higher anaphylaxis rates after hpv vaccination (0 replies)
  141. Anaphylactic-Shock: Hpv vaccine shows higher rate of anaphylaxis: study (0 replies)
  142. Anaphylactic-Shock: Anaphylaxis, beta blockade and the kounis syndrome. (0 replies)
  143. Anaphylactic-Shock: Hypersensitivity to inulin: a rare and mostly benign event (0 replies)
  144. Anaphylactic-Shock: Systemic administration of an fcgamma-fc(epsilon)-fusion protein in house dust mite sensitive nonhuman primates. (0 replies)
  145. Anaphylactic-Shock: Allergy and the cardiovascular system. (0 replies)
  146. Anaphylactic-Shock: Higher anaphylaxis rates after hpv vaccination: cmaj study (0 replies)
  147. Anaphylactic-Shock: Diagnosing hypersensitivity reactions to cephalosporins in children (0 replies)
  148. Anaphylactic-Shock: Anaphylaxis following quadrivalent human papillomavirus vaccination. (0 replies)
  149. Anaphylactic-Shock: The human papillomavirus vaccine and risk of anaphylaxis. (0 replies)
  150. Anaphylactic-Shock: Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedione (0 replies)
This is a "lo-fi" version of our main content. To view the full version with more information, formatting and images, please click here.
Invision Power Board © 2001-2009 Invision Power Services, Inc.